Combination Chemotherapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Refractory Hodgkin's Disease or Non-Hodgkin's Lymphoma

• Status: Completed
• Trial end date: 1991-07-01

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining more than one drug may kill more cancer cells. Bone marrow or peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy to kill more cancer cells.

PURPOSE: This phase II trial is studying giving high-dose chemotherapy followed by bone marrow or peripheral stem cell transplantation to see how well it works in treating patients with refractory Hodgkin's disease or non-Hodgkin's lymphoma.

• Phase: Phase 2

Details

• Lead Sponsor: Albert Einstein College of Medicine of Yeshiva University; Montefiore Medical Center
• Collaborator: National Cancer Institute (NCI)
• Treatments: Carmustine; Cisplatin; Cyclophosphamide; Etoposide; Etoposide phosphate; Lenograstim; Sargramostim